239 related articles for article (PubMed ID: 31588123)
1. Identification of a biomarker panel for improvement of prostate cancer diagnosis by volatile metabolic profiling of urine.
Lima AR; Pinto J; Azevedo AI; Barros-Silva D; Jerónimo C; Henrique R; de Lourdes Bastos M; Guedes de Pinho P; Carvalho M
Br J Cancer; 2019 Nov; 121(10):857-868. PubMed ID: 31588123
[TBL] [Abstract][Full Text] [Related]
2. Application of Urinary Volatile Organic Compounds (VOCs) for the Diagnosis of Prostate Cancer.
Gao Q; Su X; Annabi MH; Schreiter BR; Prince T; Ackerman A; Morgas S; Mata V; Williams H; Lee WY
Clin Genitourin Cancer; 2019 Jun; 17(3):183-190. PubMed ID: 30853355
[TBL] [Abstract][Full Text] [Related]
3. Furan and p-xylene as candidate biomarkers for prostate cancer.
Jiménez-Pacheco A; Salinero-Bachiller M; Iribar MC; López-Luque A; Miján-Ortiz JL; Peinado JM
Urol Oncol; 2018 May; 36(5):243.e21-243.e27. PubMed ID: 29395956
[TBL] [Abstract][Full Text] [Related]
4. GC-MS metabolomics-based approach for the identification of a potential VOC-biomarker panel in the urine of renal cell carcinoma patients.
Monteiro M; Moreira N; Pinto J; Pires-Luís AS; Henrique R; Jerónimo C; Bastos ML; Gil AM; Carvalho M; Guedes de Pinho P
J Cell Mol Med; 2017 Sep; 21(9):2092-2105. PubMed ID: 28378454
[TBL] [Abstract][Full Text] [Related]
5. Discrimination between the human prostate normal and cancer cell exometabolome by GC-MS.
Lima AR; Araújo AM; Pinto J; Jerónimo C; Henrique R; Bastos ML; Carvalho M; Guedes de Pinho P
Sci Rep; 2018 Apr; 8(1):5539. PubMed ID: 29615722
[TBL] [Abstract][Full Text] [Related]
6. Urinary Volatile Organic Compounds for the Detection of Prostate Cancer.
Khalid T; Aggio R; White P; De Lacy Costello B; Persad R; Al-Kateb H; Jones P; Probert CS; Ratcliffe N
PLoS One; 2015; 10(11):e0143283. PubMed ID: 26599280
[TBL] [Abstract][Full Text] [Related]
7. A
Thompson M; Sarabia Feria N; Yoshioka A; Tu E; Civitci F; Estes S; Wagner JT
Biol Open; 2021 Mar; 10(3):. PubMed ID: 33685856
[TBL] [Abstract][Full Text] [Related]
8. Prostate cancer screening using chemometric processing of GC-MS profiles obtained in the headspace above urine samples.
Deev V; Solovieva S; Andreev E; Protoshchak V; Karpushchenko E; Sleptsov A; Kartsova L; Bessonova E; Legin A; Kirsanov D
J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Oct; 1155():122298. PubMed ID: 32771969
[TBL] [Abstract][Full Text] [Related]
9. GC/MS-based metabolomic approach to validate the role of urinary sarcosine and target biomarkers for human prostate cancer by microwave-assisted derivatization.
Wu H; Liu T; Ma C; Xue R; Deng C; Zeng H; Shen X
Anal Bioanal Chem; 2011 Aug; 401(2):635-46. PubMed ID: 21626193
[TBL] [Abstract][Full Text] [Related]
10. Investigation of urinary volatile organic metabolites as potential cancer biomarkers by solid-phase microextraction in combination with gas chromatography-mass spectrometry.
Silva CL; Passos M; Câmara JS
Br J Cancer; 2011 Dec; 105(12):1894-904. PubMed ID: 22085842
[TBL] [Abstract][Full Text] [Related]
11. Feasibility of integrating canine olfaction with chemical and microbial profiling of urine to detect lethal prostate cancer.
Guest C; Harris R; Sfanos KS; Shrestha E; Partin AW; Trock B; Mangold L; Bader R; Kozak A; Mclean S; Simons J; Soule H; Johnson T; Lee WY; Gao Q; Aziz S; Stathatou PM; Thaler S; Foster S; Mershin A
PLoS One; 2021; 16(2):e0245530. PubMed ID: 33596212
[TBL] [Abstract][Full Text] [Related]
12. Development of a headspace-solid phase microextraction gas chromatography-high resolution mass spectrometry method for analyzing volatile organic compounds in urine: Application in breast cancer biomarker discovery.
Li X; Wen X; Luo Z; Tian Y; Qian C; Zhang J; Ling R; Duan Y
Clin Chim Acta; 2023 Feb; 540():117236. PubMed ID: 36716910
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of a 25-Gene Panel urine test for prostate cancer diagnosis and potential treatment follow-up.
Johnson H; Guo J; Zhang X; Zhang H; Simoulis A; Wu AHB; Xia T; Li F; Tan W; Johnson A; Dizeyi N; Abrahamsson PA; Kenner L; Feng X; Zou C; Xiao K; Persson JL; Chen L
BMC Med; 2020 Dec; 18(1):376. PubMed ID: 33256740
[TBL] [Abstract][Full Text] [Related]
14. Olfactory detection of prostate cancer by dogs sniffing urine: a step forward in early diagnosis.
Cornu JN; Cancel-Tassin G; Ondet V; Girardet C; Cussenot O
Eur Urol; 2011 Feb; 59(2):197-201. PubMed ID: 20970246
[TBL] [Abstract][Full Text] [Related]
15. A Panel of Biomarkers for Diagnosis of Prostate Cancer Using Urine Samples.
Guo J; Yang J; Zhang X; Feng X; Zhang H; Chen L; Johnson H; Persson JL; Xiao K
Anticancer Res; 2018 Mar; 38(3):1471-1477. PubMed ID: 29491074
[TBL] [Abstract][Full Text] [Related]
16. Identification of the metabolic signatures of prostate cancer by mass spectrometry-based plasma and urine metabolomics analysis.
Yu C; Niu L; Li L; Li T; Duan L; He Z; Zhao Y; Zou L; Wu X; Luo C
Prostate; 2021 Dec; 81(16):1320-1328. PubMed ID: 34590739
[TBL] [Abstract][Full Text] [Related]
17. Urinary Volatiles and Chemical Characterisation for the Non-Invasive Detection of Prostate and Bladder Cancers.
Tyagi H; Daulton E; Bannaga AS; Arasaradnam RP; Covington JA
Biosensors (Basel); 2021 Nov; 11(11):. PubMed ID: 34821653
[TBL] [Abstract][Full Text] [Related]
18. Optimization of training and measurement protocol for eNose analysis of urine headspace aimed at prostate cancer diagnosis.
Capelli L; Bax C; Grizzi F; Taverna G
Sci Rep; 2021 Oct; 11(1):20898. PubMed ID: 34686703
[TBL] [Abstract][Full Text] [Related]
19. Implementing a central composite design for the optimization of solid phase microextraction to establish the urinary volatomic expression: a first approach for breast cancer.
Silva CL; Perestrelo R; Silva P; Tomás H; Câmara JS
Metabolomics; 2019 Apr; 15(4):64. PubMed ID: 30997581
[TBL] [Abstract][Full Text] [Related]
20. Using gene expression from urine sediment to diagnose prostate cancer: development of a new multiplex mRNA urine test and validation of current biomarkers.
Mengual L; Lozano JJ; Ingelmo-Torres M; Izquierdo L; Musquera M; Ribal MJ; Alcaraz A
BMC Cancer; 2016 Feb; 16():76. PubMed ID: 26856686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
